USD 0.23
(-5.78%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -13 Thousand USD | 43.48% |
2022 | -23 Thousand USD | 45.24% |
2021 | -42 Thousand USD | 10.64% |
2020 | -47 Thousand USD | -129.79% |
2019 | 157.76 Thousand USD | 402.95% |
2018 | -52.07 Thousand USD | -111.59% |
2017 | 449.25 Thousand USD | -18.63% |
2016 | 552.1 Thousand USD | 461.79% |
2015 | 98.27 Thousand USD | 1685.1% |
2014 | -6200.00 USD | 90.08% |
2013 | -62.48 Thousand USD | -131331.82% |
2012 | -47.54 USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -8000.00 USD | -100.0% |
2024 Q1 | -4000.00 USD | -119.05% |
2023 Q1 | -4000.00 USD | 0.0% |
2023 Q4 | 21 Thousand USD | 250.0% |
2023 FY | -13 Thousand USD | 43.48% |
2023 Q3 | -14 Thousand USD | -366.67% |
2023 Q2 | -3000.00 USD | 25.0% |
2022 Q1 | -9000.00 USD | 0.0% |
2022 Q4 | -4000.00 USD | 20.0% |
2022 Q3 | -5000.00 USD | 0.0% |
2022 FY | -23 Thousand USD | 45.24% |
2022 Q2 | -5000.00 USD | 44.44% |
2021 FY | -42 Thousand USD | 10.64% |
2021 Q2 | -10 Thousand USD | 16.67% |
2021 Q3 | -11 Thousand USD | -10.0% |
2021 Q4 | -9000.00 USD | 18.18% |
2021 Q1 | -12 Thousand USD | -164.2% |
2020 Q4 | -4542.00 USD | 0.0% |
2020 Q2 | 97.00 USD | -95.54% |
2020 Q1 | 2174.00 USD | 114.03% |
2020 Q3 | - USD | -100.0% |
2020 FY | -47 Thousand USD | -129.79% |
2019 Q4 | -15.49 Thousand USD | -471.09% |
2019 Q2 | 110.51 Thousand USD | 332.35% |
2019 Q3 | 4175.00 USD | -96.22% |
2019 Q1 | 25.56 Thousand USD | 126.75% |
2019 FY | 157.76 Thousand USD | 402.95% |
2018 Q3 | - USD | -100.0% |
2018 FY | -52.07 Thousand USD | -111.59% |
2018 Q4 | -95.56 Thousand USD | 0.0% |
2018 Q2 | 15.27 Thousand USD | -45.84% |
2018 Q1 | 28.2 Thousand USD | -91.28% |
2017 FY | 449.25 Thousand USD | -18.63% |
2017 Q4 | 323.37 Thousand USD | 1447.23% |
2017 Q1 | 96.23 Thousand USD | 775.77% |
2017 Q2 | 8744.00 USD | -90.91% |
2017 Q3 | 20.9 Thousand USD | 139.02% |
2016 Q1 | 89.14 Thousand USD | 192.75% |
2016 Q2 | 381.73 Thousand USD | 328.2% |
2016 FY | 552.1 Thousand USD | 461.79% |
2016 Q4 | -14.24 Thousand USD | -226.04% |
2016 Q3 | 11.29 Thousand USD | -97.04% |
2015 Q1 | 75.82 Thousand USD | 326.28% |
2015 Q3 | - USD | -100.0% |
2015 Q4 | -96.11 Thousand USD | 0.0% |
2015 Q2 | 67.34 Thousand USD | -11.19% |
2015 FY | 98.27 Thousand USD | 1685.1% |
2014 Q4 | -33.5 Thousand USD | -222.7% |
2014 Q3 | 27.3 Thousand USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 100.0% |
2014 FY | -6200.00 USD | 90.08% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | -62.48 Thousand USD | 0.0% |
2013 FY | -62.48 Thousand USD | -131331.82% |
2013 Q1 | - USD | 100.0% |
2013 Q2 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | -47.54 USD | 0.0% |
2012 Q4 | -47.54 USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Akoya Biosciences, Inc. | 56.3 Million USD | 100.023% |
AngioDynamics, Inc. | 154.69 Million USD | 100.008% |
AtriCure, Inc. | 300.37 Million USD | 100.004% |
Avinger, Inc. | 2 Million USD | 100.649% |
Azenta, Inc. | 263.14 Million USD | 100.005% |
BioLife Solutions, Inc. | 46.75 Million USD | 100.028% |
The Cooper Companies, Inc. | 2.35 Billion USD | 100.001% |
Daxor Corporation | 1.1 Million USD | 101.178% |
Ekso Bionics Holdings, Inc. | 9.07 Million USD | 100.143% |
Femasys Inc. | 691.9 Thousand USD | 101.879% |
Harvard Bioscience, Inc. | 60.86 Million USD | 100.021% |
Hologic, Inc. | 2.22 Billion USD | 100.001% |
ICU Medical, Inc. | 739.87 Million USD | 100.002% |
Intuitive Surgical, Inc. | 4.72 Billion USD | 100.0% |
KORU Medical Systems, Inc. | 16.7 Million USD | 100.078% |
LeMaitre Vascular, Inc. | 127.04 Million USD | 100.01% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 89.106% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 89.106% |
Masimo Corporation | 1 Billion USD | 100.001% |
Microbot Medical Inc. | -106 Thousand USD | 87.736% |
Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 100.039% |
Merit Medical Systems, Inc. | 583.87 Million USD | 100.002% |
Nephros, Inc. | 8.4 Million USD | 100.155% |
NovoCure Limited | 381.05 Million USD | 100.003% |
NEXGEL, Inc. | 619 Thousand USD | 102.1% |
NEXGEL, Inc. | 619 Thousand USD | 102.1% |
Singular Genomics Systems, Inc. | -558 Thousand USD | 97.67% |
OraSure Technologies, Inc. | 179.42 Million USD | 100.007% |
Pro-Dex, Inc. | 14.55 Million USD | 100.089% |
Pulse Biosciences, Inc. | -1.2 Million USD | 98.923% |
Predictive Oncology Inc. | 1.14 Million USD | 101.135% |
Precision Optics Corporation, Inc. | 5.79 Million USD | 100.224% |
QuidelOrtho Corporation | 1.49 Billion USD | 100.001% |
Repligen Corporation | 315.22 Million USD | 100.004% |
Sanara MedTech Inc. | 57.13 Million USD | 100.023% |
STAAR Surgical Company | 252.65 Million USD | 100.005% |
Sharps Technology, Inc. | -891.24 Thousand USD | 98.541% |
Utah Medical Products, Inc. | 30.03 Million USD | 100.043% |
DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.001% |
Jin Medical International Ltd. | 6.78 Million USD | 100.192% |